Ryo Kodera

775 citations
16 papers · 648 indexed · h-index 10
Topics
Diabetes Treatment and Management (8 papers)Chronic Kidney Disease and Diabetes (3 papers)Advanced Glycation End Products research (3 papers)
Partner nations
JapanUnited States

In The Last Decade

Ryo Kodera

16 papers receiving 637 citations

Peers

Ryo Kodera
Comparison fields: 5 of 73
  • Endocrinology, Diabetes and Metabolism 372
  • Surgery 188
  • Molecular Biology 170
  • Nephrology 138
  • Oncology 87
Replace Nobuo Kajitani with:
Nobuo Kajitani Japan
Daisho Hirota Japan
Chikage Sato Japan
Motofumi Sasaki Japan
Chenzhong Li China
Amanda Mather Australia
Mako Yasuda‒Yamahara Japan
Mihoko Hosoba Japan
Maria Oliveira‐Souza Brazil
Harshini Mudaliar Australia
Ryo Kodera relative to Nobuo Kajitani Japan Nobuo Kajitani's profile →
Citations per field
00.5×1.5×
Nobuo Kajitani · 1×
Citations per year

Countries citing papers authored by Ryo Kodera

Since Specialization
Citations

This map shows the geographic impact of Ryo Kodera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Kodera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Kodera more than expected).

Fields of papers citing papers by Ryo Kodera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Kodera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Kodera. The network helps show where Ryo Kodera may publish in the future.

Co-authorship network of co-authors of Ryo Kodera

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Kodera. A scholar is included among the top collaborators of Ryo Kodera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Kodera. Ryo Kodera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 9
2 17
3 1
4 10
5 7
6 8
7 84
8 23
9 60
10 11
11 337
12 26
13 26
14 9
15 14
16 6

About Ryo Kodera

Ryo Kodera is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 16 papers that have together received 648 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Chronic Kidney Disease and Diabetes (3 papers) and Advanced Glycation End Products research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (372 citations), Nephrology (138 citations) and Clinical Biochemistry (69 citations). Ryo Kodera has collaborated with scholars based in Japan and United States. Frequent co-authors include Kenichi Shikata, Hirofumi Makino, Satoshi Miyamoto, Nobuo Kajitani, Daisho Hirota, Chikage Sato, Hitomi Kataoka, Motofumi Sasaki, Soichi Nishishita and Daisuke Ogawa. Their work appears in journals such as Diabetes, Biochemical and Biophysical Research Communications and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026